Adma Biologics
ADMA----
Forecast & Rating4 analysts currently cover Adma Biologics, of which 3 give a positive rating. The average price target is $17.00, about 59.2% upside from the current price of $10.68. Coverage is limited, so the data is for reference only. Data as of Oct 13, 2026; this does not constitute investment advice.
Oct 13, 2026Price forecast
$17.0059.18%
Forecast & RatingBuy
4analysts
- Strong buy50.00%
- Buy25.00%
- Hold25.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateOct 19, 2026
Forecast met49.6%
Stock price$10.68
Avg. target$25.7
High target$30
Low target$17
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.